Key result
DM challenges antiplatelet strategies through high platelet reactivity, hypercoagulability, and blunted response to standard agents.
Population
Patients with diabetes mellitus (DM)
Design
Review
Authors
Loading...
Persistent challenges warrant caution with standard antiplatelet agents in diabetes; leaves open optimal tailored regimens.
This review summarizes current antiplatelet treatment strategies and platelet abnormalities in patients with diabetes mellitus, who are at high risk for atherothrombotic complications.
Jung et al. (2015) conducted a review in Diabetes Mellitus. Antiplatelet treatment strategies was evaluated. Antiplatelet treatment strategies in patients with diabetes mellitus face challenges due to high platelet reactivity, hypercoagulability, and subdued response to standard agents.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: